105
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Study of lead-induced neurotoxicity in neural cells differentiated from adipose tissue-derived stem cells

, , , &
Pages 128-135 | Received 22 Oct 2014, Accepted 23 Nov 2014, Published online: 24 Feb 2015

References

  • Aoyama H. (2012). Developmental neurotoxicity testing: scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011. Congenit Anom (Kyoto) 52:119–21
  • Ashjian PH, Elbarbary AS, Edmonds B, et al. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111:1922–31
  • Bal-Price AK, Hogberg HT, Buzanska L, Coecke S. (2010a). Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol Teratol 32:36–41
  • Bal-Price AK, Hogberg HT, Buzanska L, et al. (2010b). In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 31:545–54
  • Baranowska-Bosiacka I, Gutowska I, Marchlewicz M, et al. (2012a). Disrupted pro- and antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to lead. Brain Res 1435:56–71
  • Baranowska-Bosiacka I, Gutowska I, Rybicka M, et al. (2012b). Neurotoxicity of lead. Hypothetical molecular mechanisms of synaptic function disorders. Neurol Neurochir Pol 46:569–78
  • Bondy SC, Campbell A. (2005). Developmental neurotoxicology. J Neurosci Re 81:605–12
  • Bosnjak ZJ. (2012). Developmental neurotoxicity screening using human embryonic stem cells. Exp Neurol 237:207–10
  • Breier JM, Radio NM, Mundy WR, Shafer TJ. (2008). Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 105:119–33
  • Buzanska L, Sypecka J, Nerini-molteni S, et al. (2009). A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells 27:2591–601
  • Cory-Slechta DA. (1995). Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 35:391–415
  • Crofton K, Fritsche E, Ylikomi T, Bal-Price A. (2014). International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes. ALTEX 31:223–4
  • Crofton KM, Mundy WR, Lein PJ, et al. (2011). Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 28:9–15
  • Crofton KM, Mundy WR, Shafer TJ. (2012). Developmental neurotoxicity testing: a path forward. Congenit Anom (Kyoto) 52:140–6
  • Davila JC, Cezar GG, Thiede M, et al. (2004). Use and application of stem cells in toxicology. Toxicol Sci 79:214–23
  • De Ugarte DA, Morizono K, Elbarbary A, et al. (2003). Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174:101–9
  • Gilbert ME, Lasley SM. (2002). Long-term consequences of developmental exposure to lead or polychlorinated biphenyls: synaptic transmission and plasticity in the rodent CNS. Environ Toxicol Pharmacol 12:105–17
  • Gimble JM, Guilak F. (2003). Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 58:137–60
  • Goldstein GW. (1992). Neurologic concepts of lead poisoning in children. Pediatr Ann 21:384–8
  • Goyer RA. (1993). Lead toxicity: current concerns. Environ Health Perspect 100:177–87
  • Grandjean P, Landrigan PJ. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368:2167–78
  • Hayess K, Riebeling C, Pirow R, et al. (2013). The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro. Toxicology 314:135–47
  • Hogberg HT, Kinsner-Ovaskainen A, Coecke S, et al. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci 113:95–115
  • Hogberg HT, Kinsner-Ovaskainen A, Hartung T, et al. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicol Appl Pharmacol 235:268–86
  • Huang F, Schneider JS. (2004). Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain. Neurotoxicology 25:1001–12
  • Jakubowski M. (2011). Low-level environmental lead exposure and intellectual impairment in children–the current concepts of risk assessment. Int J Occup Med Environ Health 24:1–7
  • Jang S, Cho HH, Cho YB, et al. (2010). Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 11:25
  • Janz R, Sudhof TC, Hammer RE, et al. (1999). Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24:687–700
  • Kermani S, Karbalaie K, Madani SH, et al. (2008). Effect of lead on proliferation and neural differentiation of mouse bone marrow-mesenchymal stem cells. Toxicol In Vitro 22:995–1001
  • Kolaja K. (2014). Stem cells and stem cell-derived tissues and their use in safety assessment. J Biol Chem 289:4555–61
  • Laurenza I, Pallocca G, Mennecozzi M, et al. (2013). A human pluripotent carcinoma stem cell-based model for in vitro developmental neurotoxicity testing: effects of methylmercury, lead and aluminum evaluated by gene expression studies. Int J Dev Neurosci 31:679–91
  • Lee JA, Cole GJ. (2000). Localization of transitin mRNA, a nestin-like intermediate filament family member, in chicken radial glia processes. J Comp Neurol 418:473–83
  • Lidsky TI, Schneider JS. (2003). Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126:5–19
  • Liu W, Deng Y, Liu Y, et al. (2013). Stem cell models for drug discovery and toxicology studies. J Biochem Mol Toxicol 27:17–27
  • Mason LH, Harp JP, Han DY. (2014). Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int 2014:840547
  • Morizono K, De Ugarte DA, Zhu M, et al. (2003). Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Ther 14:59–66
  • Neal AP, Stansfield KH, Worley PF, et al. (2010). Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling. Toxicol Sci 116:249–63
  • Nemsadze K, Sanikidze T, Ratiani L, et al. (2009). Mechanisms of lead-induced poisoning. Georgian Med News 172–173:92–6
  • Pfaffl MW, Horgan GW, Dempfle L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
  • Prasanthi RP, Devi CB, Basha DC, et al. (2010). Calcium and zinc supplementation protects lead (Pb)-induced perturbations in antioxidant enzymes and lipid peroxidation in developing mouse brain. Int J Dev Neurosci 28:161–7
  • Radio NM, Mundy WR. (2008). Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29:361–76
  • Reddy GR, Zawia NH. (2000). Lead exposure alters Egr-1 DNA-binding in the neonatal rat brain. Int J Dev Neurosci 18:791–5
  • Rice D, Barone S Jr. (2000). Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108:511–33
  • Safford KM, Hicok KC, Safford SD, et al. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294:371–9
  • Soodi M, Sharifzadeh M, Naghdi N, et al. (2007). Systemic and developmental exposure to lead causes spatial memory deficits and a reduction in COX-2 immunoreactivity in the hippocampus of male rats. J Neurosci Res 85:3183–92
  • Strem BM, Hicok KC, Zhu M, et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132–41
  • Taha MF, Hedayati V. (2010). Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell 42:211–16
  • Taha MF, Javeri A, Kheirkhah O, et al. (2014). Neural differentiation of mouse embryonic and mesenchymal stem cells in a simple medium containing synthetic serum replacement. J Biotechnol 172:1–10
  • Tong S. (1998). Lead exposure and cognitive development: persistence and a dynamic pattern. J Paediatr Child Health 34:114–18
  • Visan A, Hayess K, Sittner D, et al. (2012). Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro. Neurotoxicology 33:1135–46
  • Zavan B, Michelotto L, Lancerotto L, et al. (2010a). Neural potential of a stem cell population in the adipose and cutaneous tissues. Neurol Res 32:47–54
  • Zavan B, Vindigni V, Gardin C, et al. (2010b). Neural potential of adipose stem cells. Discov Med 10:37–43
  • Zawia NH, Sharan R, Brydie M, et al. (1998). Sp1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression. Brain Res Dev Brain Res 107:291–8
  • Zuk PA, Zhu M, Ashjian P, et al. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–95

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.